These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 2387260

  • 1. Measurement of circulating parathyroid hormone-related protein in rats with humoral hypercalcemia of malignancy using a two-site immunoradiometric assay.
    Gaich G, Burtis WJ.
    Endocrinology; 1990 Sep; 127(3):1444-9. PubMed ID: 2387260
    [Abstract] [Full Text] [Related]

  • 2. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
    Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP, Olson BR, Wu TL, Mitnick ME, Broadus AE, Stewart AF.
    N Engl J Med; 1990 Apr 19; 322(16):1106-12. PubMed ID: 2320080
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regulation in vivo of the growth of Leydig cell tumors by antisense ribonucleic acid for parathyroid hormone-related peptide.
    Rabbani SA, Gladu J, Liu B, Goltzman D.
    Endocrinology; 1995 Dec 19; 136(12):5416-22. PubMed ID: 7588290
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Isolation of 16,000-dalton parathyroid hormone-like proteins from two animal tumors causing humoral hypercalcemia of malignancy.
    Weir EC, Burtis WJ, Morris CA, Brady TG, Insogna KL.
    Endocrinology; 1988 Dec 19; 123(6):2744-51. PubMed ID: 3197642
    [Abstract] [Full Text] [Related]

  • 7. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M, Kremer R, Goltzman D, Rabbani SA.
    J Clin Invest; 1993 Jun 19; 91(6):2416-22. PubMed ID: 8514854
    [Abstract] [Full Text] [Related]

  • 8. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK, Chuang MJ, Lu CC, Hao LJ, Yang CY, Han TM, Lam HC.
    J Endocrinol Invest; 1997 Jun 19; 20(7):404-9. PubMed ID: 9309539
    [Abstract] [Full Text] [Related]

  • 9. Calcium-sensing receptor induces proliferation through p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase but not extracellularly regulated kinase in a model of humoral hypercalcemia of malignancy.
    Tfelt-Hansen J, Chattopadhyay N, Yano S, Kanuparthi D, Rooney P, Schwarz P, Brown EM.
    Endocrinology; 2004 Mar 19; 145(3):1211-7. PubMed ID: 14645111
    [Abstract] [Full Text] [Related]

  • 10. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
    Brown GM, Morris CA, Mitnick MA, Insogna KL.
    J Bone Miner Res; 1990 Oct 19; 5(10):1037-41. PubMed ID: 1964358
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma.
    Ikeda K, Ohno H, Hane M, Yokoi H, Okada M, Honma T, Yamada A, Tatsumi Y, Tanaka T, Saitoh T.
    J Clin Endocrinol Metab; 1994 Nov 19; 79(5):1322-7. PubMed ID: 7962324
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.
    Grill V, Ho P, Body JJ, Johanson N, Lee SC, Kukreja SC, Moseley JM, Martin TJ.
    J Clin Endocrinol Metab; 1991 Dec 19; 73(6):1309-15. PubMed ID: 1955513
    [Abstract] [Full Text] [Related]

  • 15. Cinacalcet attenuates hypercalcemia observed in mice bearing either Rice H-500 Leydig cell or C26-DCT colon tumors.
    Colloton M, Shatzen E, Wiemann B, Starnes C, Scully S, Henley C, Martin D.
    Eur J Pharmacol; 2013 Jul 15; 712(1-3):8-15. PubMed ID: 23623934
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detection of parathyroid hormone-related protein in cats with humoral hypercalcemia of malignancy.
    Bolliger AP, Graham PA, Richard V, Rosol TJ, Nachreiner RF, Refsal KR.
    Vet Clin Pathol; 2002 Jul 15; 31(1):3-8. PubMed ID: 12019470
    [Abstract] [Full Text] [Related]

  • 18. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in the canine anal sac apocrine gland adenocarcinoma (CAC-8) nude mouse model.
    Gröne A, Weckmann MT, Blomme EA, Capen CC, Rosol TJ.
    Vet Pathol; 1998 Sep 15; 35(5):344-51. PubMed ID: 9754539
    [Abstract] [Full Text] [Related]

  • 19. Extracellular calcium-sensing receptor (CaR) expression and its potential role in parathyroid hormone-related peptide (PTHrP) secretion in the H-500 rat Leydig cell model of humoral hypercalcemia of malignancy.
    Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Brown EM.
    Biochem Biophys Res Commun; 2000 Mar 16; 269(2):427-32. PubMed ID: 10708570
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
    Rosol TJ, Nagode LA, Couto CG, Hammer AS, Chew DJ, Peterson JL, Ayl RD, Steinmeyer CL, Capen CC.
    Endocrinology; 1992 Sep 16; 131(3):1157-64. PubMed ID: 1505457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.